Author

Seth A. Nelson

Van Andel Institute

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Andreas Due ØrskoviD· 1 shared Anh Van Nguyen· 1 shared Ben YoungbloodiD· 1 shared Benjamin K. JohnsoniD· 1 shared Caitlin C. ZebleyiD· 1 shared Casey Lee O'ConnelliD· 1 shared Guillermo Urrutia· 1 shared H. Josh JangiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Andreas Due ØrskovORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Bone marrow microenvironment signatures associate with patient survival after guadecitabine and atezolizumab therapy in HMA-resistant MDS

H. Josh Jang, Guillermo Urrutia, Andreas Due Ørskov, Anh Van Nguyen, Hyeon Jin Kim, Seth A. Nelson, Hyein Lee, Ryan S. Burgos, Benjamin K. Johnson, Marc Wegener, Katelyn Becker, Marie Adams, Rachael T. C. Sheridan, Zachary H. Ramjan, Scott A. Givan, , Peter A. Jones

The paper analyzes bone marrow microenvironment changes in HMA-resistant MDS patients treated with guadecitabine and atezolizumab, finding that long-term survivors show reduced immunosuppressive monocytes and expanded effector lymphocytes.

Blood Neoplasia · May 5, 2026Peer-reviewedCancer Biology